NCT02964078 2026-02-10
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
H. Lee Moffitt Cancer Center and Research Institute
University of Michigan
Columbia University
Stanford University
Barretos Cancer Hospital